Perception Capital Corp. II
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCCT research report →
Price Chart
About the company
Perception Capital Corp. II does not currently engage in significant operations. Its primary objective is to facilitate a strategic business combination, which may include a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.
- CEO
- Richard W. Gaenzle Jr.
- IPO
- 2021
- HQ
- Wayzata, MN, US
Get TickerSpark's AI analysis on PCCT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $15.40
- 52W Low
- $5.50
- 50D MA
- $10.83
- 200D MA
- $10.83
- Beta
- 0.00
- RSI (14)
- 18
- Avg Volume
- 49.21K
No earnings-call transcripts are available for PCCT yet.
- Free Float
- 26.2%
- Shares Outstanding
- 7.83M
- Float Shares
- 2.05M
of shares held by institutions
20 13F filers
Buy/sell ratio 5.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Spring Creek Capital LLC | 25.00K | ▲ 25.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 24, 23 | Mosolf Joerg | buy | 10,000 |
| Oct 25, 23 | Semkiw Brian | buy | 297 |
| Oct 24, 23 | Semkiw Brian | buy | 303 |
| Oct 24, 23 | Semkiw Brian | buy | 1,596 |
| Oct 19, 23 | Mosolf Joerg | other | 1,812,062 |
| Oct 19, 23 | Mendes Rui | other | 1,279,577 |
| Oct 19, 23 | Mendes Rui | other | 873,625 |
| Oct 19, 23 | Fernandes Leonardo | other | 108,439 |
| Oct 19, 23 | Fernandes Leonardo | other | 74,036 |
| Oct 19, 23 | Mosolf Joerg | other | 1,935,944 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PCCT coverage
Recent articles, reports, and earnings notes.
No research on PCCT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PCCT report →GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT
zacks.com · Mar 24
Spectaire Inc. and Perception Capital Corp. II Complete Business Combination
globenewswire.com · Oct 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.